Our mission is to become a recognized leader in the development, commercialization, and clinical application of artificial organ and tissue repair technologies for the treatment of pathologic conditions such as end organ failure, congenital defects, trauma, and chronic insidious disease.
Who we are
ECMedical is an early-stage Pittsburgh-based life sciences start up company specializing in Tissue Engineering, Regenerative Medicine, and Genetic Engineering for the development and clinical application of fully compatible artificial organs and next generation medical device technologies for tissue repair.
Our technologies include implantable hardware, biomaterial-synthetic biohybrid medical devices, biomimetic tissue interfaces, and CRISPR-Cas9 gene editing strategies to promote:
Restoration of native tissue function
Reduction of chronic inflammation
Reduction of surgical site complications.
ECMedical is currently being funded from the following sources:
Darpa/DoD Phase I STTR Contract
Consulting and contracted research